JPLA
ZOM

Joseph P. Lucia & Associates’s Zomedica Corp. ZOM Stock Holding History

Joseph P. Lucia & Associates’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-750
Closed – – 601
2021
Q3 		$0 Buy
+750
New +$443 ﹤0.01% 638

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Joseph P. Lucia & Associates's ZOM Position: Q4 2021 in Review

Joseph P. Lucia & Associates sold out of Zomedica Corp. (ZOM) in Q4 2021, closing a stake of 750 shares.

Joseph P. Lucia & Associates first reported a position in ZOM in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q4 2021.

  • Joseph P. Lucia & Associates reported no remaining Zomedica Corp. position as of Q4 2021 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 750 Zomedica Corp. shares in Q4 2021.
  • Joseph P. Lucia & Associates first reported a position in Zomedica Corp. in Q3 2021 and held it in 1 quarter.
  • Joseph P. Lucia & Associates's Zomedica Corp. position peaked at $0 in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2021.

Based on Joseph P. Lucia & Associates's 13F filing for Q4 2021, filed 4 Feb 2022.